Risk of Each of the Five Lung Lobectomies: A Society of Thoracic Surgeons Database Analysis

医学 围手术期 逻辑回归 数据库 外科 全肺切除术 死亡率 心胸外科 内科学 计算机科学
作者
Philip A. Linden,Mark I. Block,Yaron Perry,Henning A. Gaissert,Stephanie J. Worrell,Maria V. Grau‐Sepulveda,Andrzej S. Kosinski,Oliver K. Jawitz,Matthew G. Hartwig,Christopher W. Towe
出处
期刊:The Annals of Thoracic Surgery [Elsevier BV]
卷期号:114 (5): 1871-1877 被引量:9
标识
DOI:10.1016/j.athoracsur.2022.03.012
摘要

The perioperative risk of pulmonary lobectomy as a solitary procedure has been extensively studied, yet the differences in outcomes between lobes, which have unique anatomy and a different amount of lung parenchyma, are entirely unknown. The purpose of this study was to define the risk of each of the 5 lobectomies.The Society of Thoracic Surgeons Database was queried for patients undergoing lobectomy between 2008 and 2018. Patient and disease characteristics, operative variables, major morbidity, and 30-day mortality were examined. A multivariable logistic regression model (using the same variables in the current Society of Thoracic Surgeons lobectomy risk model) was developed to assess the contribution of lobectomy site to adverse outcomes.There were 65 006 patients analyzed. Adjusted perioperative mortality rate is lowest for right middle lobe (RML), 0.63%; intermediate for right upper lobe (RUL), left upper lobe (LUL), and left lower lobe (LLL), 1.08 to 1.24%; and highest for right lower lobe (RLL), 1.63%. The adjusted major morbidity rate is lowest for RML, 5.36%; intermediate for LLL and LUL, 7.82% to 8.33%; and highest for RUL and RLL, 8.94% to 9.32%. Adjusted intraoperative transfusion rate is lowest for RML, 1.37%; intermediate for RLL and LLL, 1.81% to 1.94%; and highest for RUL and LUL, 2.47% to 2.72%.There are clear differences in postoperative outcomes by lobectomy location. Mortality, major morbidity, and transfusion rate are lowest for RML but vary across other lobectomies. These differences should be appreciated in evaluating risk of operation, deciding on best therapy, counseling patients, and comparing outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
孙美娜发布了新的文献求助10
1秒前
Lily完成签到,获得积分10
1秒前
1秒前
谢书南完成签到,获得积分10
1秒前
Elizabeth12138完成签到 ,获得积分10
2秒前
标致访旋完成签到,获得积分10
2秒前
忐忑的鞋垫完成签到,获得积分10
2秒前
3秒前
熟睡的妻子完成签到,获得积分10
4秒前
小叶子完成签到,获得积分10
4秒前
OpalLi完成签到 ,获得积分10
4秒前
xuezhixia完成签到,获得积分10
5秒前
Betty完成签到,获得积分10
5秒前
5秒前
调皮的逍遥完成签到,获得积分10
5秒前
6秒前
田様应助DWRH采纳,获得10
6秒前
Itazu完成签到,获得积分10
6秒前
Apricity完成签到,获得积分10
6秒前
6秒前
靓丽的斓发布了新的文献求助10
6秒前
正直的雅绿完成签到,获得积分10
6秒前
6秒前
somajason完成签到,获得积分10
7秒前
种田完成签到,获得积分10
7秒前
一木完成签到,获得积分10
7秒前
激昂的秀发完成签到,获得积分10
7秒前
7秒前
肆三一完成签到,获得积分10
8秒前
Owen应助胡锐采纳,获得10
8秒前
Orange应助xuezhixia采纳,获得10
8秒前
猫橘汽水完成签到,获得积分10
9秒前
tachang完成签到,获得积分10
9秒前
标致的冷梅完成签到,获得积分10
9秒前
聪慧的若山完成签到,获得积分10
9秒前
顾矜应助任迷迷采纳,获得10
10秒前
Aurora完成签到,获得积分10
10秒前
xiekai301发布了新的文献求助10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Principles of town planning: translating concepts to applications 1000
内視鏡的に摘除しえた十二指腸乳頭部腫瘍の2例 660
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Interpolation and Regression Models for the Chemical Engineer: Solving Numerical Problems 400
The Neuroscience of Language 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7688328
求助须知:如何正确求助?哪些是违规求助? 9250832
关于积分的说明 19965779
捐赠科研通 7261163
什么是DOI,文献DOI怎么找? 3289997
关于科研通互助平台的介绍 2446950
邀请新用户注册赠送积分活动 2294727